Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biospecifics Tech Cp (NQ: BSTC )

88.53 USD UNCHANGED
Last Price Updated: 4:21 PM EST, Dec 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biospecifics Tech Cp

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
Biotech stocks rebounded in the holiday-shortened week ending July 2as investors reacted to pending clinical trial readouts and ... 
Tags PCVX Biotech OBSV
From Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular ... 
Tags VIE Trading Ideas ALXN
From Benzinga
SMMV's Holdings Imply 10% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ATNX IBB HTBX
From Benzinga
BioSpecifics Reports First Quarter 2020 Financial and Operating Results
- 19% year-over-year increase in royalty revenues for XIAFLEX® 
From PR Newswire
BioSpecifics Names Joseph Truitt as Permanent Chief Executive Officer
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed... 
From PR Newswire
BioSpecifics Adopts Replacement Stockholder Rights Plan
Stockholders to Vote on Rights Plan at 2020 Annual Meeting 
From PR Newswire
BioSpecifics Appoints Mike Sherman and Corey Fishman to Board of Directors
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed... 
From PR Newswire
BioSpecifics Appoints Joseph Truitt as Interim Chief Executive Officer
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed... 
From PR Newswire
How The Pieces Add Up: SMMV Targets $35
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags NVS Earnings ERYP
From Benzinga
26.4% Return Seen to Date on SmarTrend Biospecifics Tec Call (BSTC)
SmarTrend identified a Downtrend for Biospecifics Tec (NASDAQ:BSTC) on February 25th, 2020 at $60.39. In approximately 3 weeks, Biospecifics Tec has returned 26.36% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
BioSpecifics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
- 16% year-over-year increase in royalty revenues for XIAFLEX® 
From PR Newswire
BSTC Crosses Below Key Moving Average Level
In trading on Friday, shares of Biospecifics Technologies Corp. (BSTC) crossed below their 200 day moving average of $57.09, changing hands as low as $50.75 per share.. 
Tags Stocks
From Market News Video
How The Parts Add Up: EXT Targets $40
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Biospecifics Technologies (BSTC) Shares Cross Below 200 DMA
In trading on Friday, shares of Biospecifics Technologies Corp. (BSTC) crossed below their 200 day moving average of $57.68, changing hands as low as $56.01 per share.. 
Tags Stocks
From Market News Video
19.1% Return Seen to Date on SmarTrend Biospecifics Tec Call (BSTC)
SmarTrend identified an Uptrend for Biospecifics Tec (NASDAQ:BSTC) on November 5th, 2019 at $50.10. In approximately 1 month, Biospecifics Tec has returned 19.09% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
BSTC Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of Biospecifics Technologies Corp. (BSTC) crossed above their 200 day moving average of $59.12, changing hands as high as $59.20 per share.. 
Tags Stocks
From Market News Video
SMLF's Underlying Holdings Imply 12% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BioSpecifics Reports Third Quarter 2019 Financial and Operating Results
- 15% year-over-year increase in royalty revenues for XIAFLEX® 
From PR Newswire
Hedge Funds Have Never Been Less Bullish On Diplomat Pharmacy Inc. (DPLO)
What is the key hedge fund action surrounding Diplomat Pharmacy Inc.? 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class product marketed as XIAFLEX® in... 
From PR Newswire
The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... 
Tags NLNK MRK News
From Benzinga
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags ISRG FULC DFFN
From Benzinga
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... 
Tags ORGS NKTR FIXX
From Benzinga
Biospecifics Technologies is Now Oversold (BSTC)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
BioSpecifics Technologies Corp. Names J. Kevin Buchi as Chief Executive Officer
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed... 
From PR Newswire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning saw 277 companies set new 52-week lows. Areas of Significance: Charles Schwab (NYSE: SCHW) was the largest firm ... 
Tags MAANF Market News MC
From Benzinga
How The Pieces Add Up: SMLF Targets $46
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks That Hit 52-Week Lows On Thursday
Before 10 a.m E.T on Thursday, 301 companies hit new 52-week lows. Noteables: 3M (NYSE: MMM) was the biggest company on a ... 
Tags BOSSY SDRL LOGM
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.